Nerve Monitors Recalled by Medtronic

Healthcare professionals are being notified by the FDA of a Medtronic medical device recall regarding their nerve tracking system, which has been connected to ten injuries. The problem was assigned a Class I recall label by the government, which is its highest risk classification.

According to the FDA, the gadgets are being corrected and will remain on the market; their removal from use or sale is not part of the recall.

The FDA Notice Said: “The use of affected product may cause serious adverse health consequences, including nerve damage, facial nerve damage, nerve weakening (paresis), and nerve paralysis.”

Version 1.5.4 of the program is being deployed, according to Medtronic, to address the false negative issue. The business is encouraging customers to adhere to the medical standards established for individuals who are presently under observation until the program is deployed.